Hello, Welcome to Shine Consultant !
Conference Sponsor
7
2018 - 08 - 30
点击次数:
Hangzhou Tigermed Consulting Co., Ltd(stock symbol: 300347) is a leading Contract Research Organization (CRO) in China dedicated to provide professional full clinical trial services. Since inception in 2004, Tigermed has been committed to accelerating medical product development with costs efficiency and quality. Headquartered in Hangzhou, Tigermed operates 33 subsidiaries, 63 offices across China and 12 overseas offices in Hong Kong China, Taiwan China, USA, Switzerland, Canada, Korea, Australia, Japan, Malaysia, Singapore , India and Romania with over 3600 full time staffs. Tigermed has serviced more than 600 local and global clients in the conduct of over 1060 clinical trials. Tigermed is recognized as “The Innovative CRO” in China,owning to our involvement of  over 150 innovative drugs.Contact: www.tigermed.net  Email: bd@tigermed.net
8
2018 - 08 - 30
点击次数:
SanyouBio is a biological high-tech enterprises majorly committed to innovative therapeutic monoclonal antibody development and services.It was established in Shanghai in May 2015, and has invested totally more than 20 million yuan. In the state-level economic and technological development zone "Shanghai Caohejing Hi-tech Park ", SanyouBio has the established innovative antibody R & D platform with thousands of square meters, equipped facilities and advanced technology platforms including "comprehensive protein expression and antigen preparation", "diversified methods of antibody generation", "the ultra-comprehensive antibody engineering", "systemic in vitro efficacy and functional screening for therapeutic antibody", "efficient medicinal evaluation of therapeutic antibody", "integration of innovative therapeutic monoclonal antibody discovery " and many other international-advanced technologies and sub-platforms. Now it is committed to building preclinical technology platforms for drug discovery with international standard.
9
2018 - 08 - 30
点击次数:
Hangzhou Tigermed Consulting Co., Ltd(stock symbol: 300347) is a leading Contract Research Organization (CRO) in China dedicated to provide professional full clinical trial services. Since inception in 2004, Tigermed has been committed to accelerating medical product development with costs efficiency and quality. Headquartered in Hangzhou, Tigermed operates 33 subsidiaries, 63 offices across China and 12 overseas offices in Hong Kong China, Taiwan China, USA, Switzerland, Canada, Korea, Australia, Japan, Malaysia, Singapore , India and Romania with over 3600 full time staffs. Tigermed has serviced more than 600 local and global clients in the conduct of over 1060 clinical trials. Tigermed is recognized as “The Innovative CRO” in China,owning to our involvement of  over 150 innovative drugs.Contact: www.tigermed.net  Email: bd@tigermed.net